Beaglee Inc
TSE:3981
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Beaglee Inc
TSE:3981
|
JP |
|
Fuso Chemical Co Ltd
TSE:4368
|
JP |
|
S
|
Sambu Engineering & Construction Co Ltd
KRX:001470
|
KR |
|
K
|
Kyverna Therapeutics Inc
NASDAQ:KYTX
|
US |
Balance Sheet
Balance Sheet Decomposition
Beaglee Inc
Beaglee Inc
Balance Sheet
Beaglee Inc
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
204
|
789
|
639
|
1 514
|
574
|
1 665
|
3 230
|
3 545
|
4 218
|
4 825
|
5 119
|
5 294
|
|
| Cash Equivalents |
204
|
789
|
639
|
1 514
|
574
|
1 665
|
3 230
|
3 545
|
4 218
|
4 825
|
5 119
|
5 294
|
|
| Short-Term Investments |
0
|
0
|
0
|
300
|
300
|
300
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1 267
|
1 393
|
1 739
|
1 583
|
1 673
|
1 278
|
4 456
|
4 494
|
4 480
|
4 048
|
3 291
|
3 159
|
|
| Accounts Receivables |
1 267
|
1 362
|
1 709
|
1 553
|
1 548
|
1 278
|
4 456
|
4 395
|
4 330
|
3 994
|
3 258
|
3 130
|
|
| Other Receivables |
0
|
30
|
30
|
30
|
125
|
0
|
0
|
99
|
150
|
54
|
33
|
28
|
|
| Inventory |
0
|
0
|
0
|
2
|
3
|
4
|
78
|
56
|
59
|
59
|
64
|
51
|
|
| Other Current Assets |
64
|
92
|
67
|
79
|
85
|
45
|
89
|
81
|
51
|
77
|
106
|
120
|
|
| Total Current Assets |
1 536
|
2 273
|
2 446
|
3 479
|
2 635
|
3 292
|
7 853
|
8 176
|
8 808
|
9 009
|
8 580
|
8 624
|
|
| PP&E Net |
64
|
38
|
42
|
35
|
35
|
38
|
51
|
62
|
67
|
67
|
63
|
131
|
|
| PP&E Gross |
64
|
38
|
42
|
35
|
35
|
38
|
51
|
62
|
67
|
67
|
63
|
131
|
|
| Accumulated Depreciation |
181
|
104
|
97
|
105
|
110
|
120
|
198
|
160
|
167
|
170
|
183
|
160
|
|
| Intangible Assets |
405
|
331
|
213
|
148
|
408
|
635
|
1 633
|
1 414
|
1 063
|
814
|
600
|
437
|
|
| Goodwill |
4 831
|
4 470
|
4 228
|
3 984
|
3 740
|
3 717
|
10 273
|
9 590
|
8 919
|
8 328
|
7 738
|
7 147
|
|
| Long-Term Investments |
0
|
1
|
1
|
1
|
205
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
66
|
46
|
43
|
42
|
82
|
71
|
226
|
216
|
183
|
166
|
314
|
218
|
|
| Other Assets |
4 831
|
4 470
|
4 228
|
3 984
|
3 740
|
3 717
|
10 273
|
9 590
|
8 919
|
8 328
|
7 738
|
7 147
|
|
| Total Assets |
6 902
N/A
|
7 160
+4%
|
6 971
-3%
|
7 688
+10%
|
7 105
-8%
|
7 753
+9%
|
20 036
+158%
|
19 458
-3%
|
19 040
-2%
|
18 385
-3%
|
17 295
-6%
|
16 557
-4%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
561
|
649
|
883
|
831
|
992
|
1 088
|
2 943
|
3 057
|
3 311
|
3 437
|
3 229
|
3 090
|
|
| Accrued Liabilities |
0
|
190
|
143
|
85
|
62
|
98
|
268
|
281
|
201
|
63
|
183
|
107
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
2 000
|
2 000
|
2 000
|
2 000
|
2 000
|
2 000
|
|
| Current Portion of Long-Term Debt |
500
|
500
|
500
|
240
|
240
|
240
|
940
|
820
|
1 020
|
1 020
|
1 020
|
1 020
|
|
| Other Current Liabilities |
385
|
790
|
507
|
718
|
328
|
1 231
|
2 082
|
1 879
|
2 145
|
1 947
|
1 591
|
1 511
|
|
| Total Current Liabilities |
1 446
|
2 129
|
2 033
|
1 874
|
1 622
|
2 657
|
8 233
|
8 036
|
8 677
|
8 467
|
8 023
|
7 728
|
|
| Long-Term Debt |
2 600
|
2 100
|
1 600
|
840
|
600
|
360
|
6 245
|
5 425
|
3 825
|
2 805
|
1 785
|
765
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
351
|
326
|
224
|
160
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
4 046
N/A
|
4 229
+5%
|
3 633
-14%
|
2 714
-25%
|
2 222
-18%
|
3 017
+36%
|
14 829
+392%
|
13 787
-7%
|
12 725
-8%
|
11 432
-10%
|
9 808
-14%
|
8 493
-13%
|
|
| Equity | |||||||||||||
| Common Stock |
1 374
|
1 374
|
1 374
|
1 852
|
1 863
|
1 869
|
1 876
|
1 883
|
1 893
|
1 901
|
1 906
|
1 911
|
|
| Retained Earnings |
30
|
184
|
591
|
1 270
|
1 531
|
1 372
|
1 824
|
2 268
|
2 885
|
3 501
|
4 718
|
5 282
|
|
| Additional Paid In Capital |
1 373
|
1 373
|
1 373
|
1 852
|
1 862
|
1 868
|
1 875
|
1 883
|
1 893
|
1 901
|
1 906
|
1 910
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
373
|
373
|
368
|
363
|
357
|
350
|
1 044
|
1 040
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2 856
N/A
|
2 931
+3%
|
3 338
+14%
|
4 974
+49%
|
4 883
-2%
|
4 736
-3%
|
5 207
+10%
|
5 672
+9%
|
6 315
+11%
|
6 953
+10%
|
7 487
+8%
|
8 064
+8%
|
|
| Total Liabilities & Equity |
6 902
N/A
|
7 160
+4%
|
6 971
-3%
|
7 688
+10%
|
7 105
-8%
|
7 753
+9%
|
20 036
+158%
|
19 458
-3%
|
19 040
-2%
|
18 385
-3%
|
17 295
-6%
|
16 557
-4%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
5
|
5
|
5
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
|